NCT07458477

Brief Summary

According to the WHO (February 2, 2024): More than 5% of the world's population, or 430 million people (including 34 million children), need rehabilitation services due to disabling hearing loss. It is estimated that 700 million people will be affected by 2050, or one in 10 people. It is estimated that by 2050, nearly 2.5 billion people will have some degree of hearing loss. In most cases, audiometric testing involves determining the patient's tonal thresholds and speech recognition thresholds. The Hearing Space device is a digital audiometer that can perform both tonal and speech audiometry. This device stands out because it allows users to calibrate its transducers themselves via a guided, automated procedure. This procedure ensures that the calibration complies with the relevant calibration standards.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 9, 2026

Completed
Last Updated

July 1, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

March 4, 2026

Last Update Submit

June 30, 2026

Conditions

Keywords

Audiometric testsHearing Space Audiometer

Outcome Measures

Primary Outcomes (1)

  • auditory threshold levels and speech recognition thresholds

    Measurements of pure-tone audiometric thresholds and speech recognition thresholds will be taken for each of the patient's ears using the Hearing Space digital audiometer and the Interacoustic AC40 physical audiometer (in random order). The results obtained will then be statistically compared to determine whether or not there is a significant difference between the results obtained by the two devices.

    From inclusion to the end of the intervention (40 minutes on average)

Study Arms (2)

Hearing Space audiometer first

EXPERIMENTAL

Hearing Space audiometer first, then AC40 audiometer

Device: Hearing Space audiometer first, then AC40 audiometer

AC40 audiometer first

EXPERIMENTAL

AC40 audiometer first, then Hearing Space audiometer

Device: AC40 audiometer first, then Hearing Space audiometer

Interventions

All patients will be tested by Hearing Space audiometer first, then AC40 audiometer

Hearing Space audiometer first

All patients will be tested by AC40 audiometer first, then Hearing Space audiometer

AC40 audiometer first

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who have come to the ENT department for an audiometric examination
  • Adult patients (aged 18 or over), regardless of weight, gender, ethnicity, etc.
  • Patients whose native language is French.
  • Able to understand instructions. Person affiliated with or beneficiary of a social security system.

You may not qualify if:

  • Patients with known/confirmed unilateral cochlear deafness
  • Adults deprived of liberty or under guardianship
  • Pregnant women
  • Patients with only one ear

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre hospitalier du Mans

Le Mans, 72000, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2026

First Posted

March 9, 2026

Study Start

November 7, 2025

Primary Completion

January 12, 2026

Study Completion

January 12, 2026

Last Updated

July 1, 2026

Record last verified: 2026-03

Locations